The Financial Industry Regulatory Authority fined Morgan Stanley $10 million for deficiencies in its anti-money-laundering program, the regulator said.
Prevention of money laundering has become a high priority for regulators, a fact FINRA underlined by announcing the penalties against Morgan Stanley.
FINRA “continues to find problems with the adequacy of some firms' overall AML programs, including allocation of AML monitoring responsibilities, data integrity in AML automated surveillance systems, and firm resources for AML programs," Susan Schroeder, executive vice president of the regulator’s department of enforcement, said in a statement.
In recent years, FINRA has also penalized other brokerage firms over anti-money-laundering issues.
FINRA found deficiencies in Morgan Stanley’s AML program during a five-year period. Among those shortcomings: The firm’s automated surveillance system did not receive critical data, including information about transfers to and from countries known for having high money-laundering risk.
The wirehouse also failed to do enough to review alerts generated by its automated AML surveillance system. Morgan Stanley analysts sometimes closed alerts without sufficiently documenting investments of potentially suspicious wire transfers, according to FINRA.
The regulator says it will keep an eye on issues like cybersecurity and cryptocurrencies.
Advisors from across 79 branches were involved in selling offerings to family members and other brokers, including stock in Facebook, General Motors, LinkedIn and Twitter.
The regulator laid out detailed guidelines for how planners should be communicating with clients electronically.
Finally, Morgan Stanley’s AML department did not reasonably monitor client trades in penny stocks for potentially suspicious activity, according to FINRA. The firm’s clients deposited approximately 2.7 billion shares of penny stocks, resulting in sales totaling approximately $164 million, the regulator says.
FINRA says that it arrived at the $10 million fine after considering the “extraordinary corrective measures” that Morgan Stanley took to improve its AML program; this included more robust staffing and enhancements to its monitoring system.
Morgan Stanley neither admitted nor denied the charges, but consented to the entry of FINRA's findings, according to the regulator.
“We are pleased to have resolved this matter from several years ago. We continuously work to strengthen our controls and have been recognized by FINRA for the extraordinary steps we have taken to expand and enhance our AML program,” a Morgan Stanley spokeswoman said in a statement.
